Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41


Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation.

Mumm S, Gottesman GS, Wenkert D, Campeau PM, Nenninger A, Huskey M, Bijanki VN, Veis DJ, Barnes AM, Marini JC, Stolina M, Zhang F, McAlister WH, Whyte MP.

Bone. 2020 Jan;130:115047. doi: 10.1016/j.bone.2019.115047. Epub 2019 Aug 28.


TGF-β Initiates β-Catenin-Mediated CTGF Secretory Pathway in Old Bovine Nucleus Pulposus Cells: A Potential Mechanism for Intervertebral Disc Degeneration.

Wu Q, Mathers C, Wang EW, Sheng S, Wenkert D, Huang JH.

JBMR Plus. 2018 Jul 10;3(2):e10069. doi: 10.1002/jbm4.10069. eCollection 2019 Feb.


Risk of subsequent fracture after prior fracture among older women.

Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, Curtis JR.

Osteoporos Int. 2019 Jan;30(1):79-92. doi: 10.1007/s00198-018-4732-1. Epub 2018 Nov 19.


Identification of a panel of genes as a prognostic biomarker for glioblastoma.

Wang F, Zheng Z, Guan J, Qi D, Zhou S, Shen X, Wang F, Wenkert D, Kirmani B, Solouki T, Fonkem E, Wong ET, Huang JH, Wu E.

EBioMedicine. 2018 Nov;37:68-77. doi: 10.1016/j.ebiom.2018.10.024. Epub 2018 Oct 16.


Hypophosphatasia: Natural history study of 101 affected children investigated at one research center.

Whyte MP, Wenkert D, Zhang F.

Bone. 2016 Dec;93:125-138. doi: 10.1016/j.bone.2016.08.019. Epub 2016 Aug 27.


Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease.

Gottesman GS, Madson KL, McAlister WH, Nenninger A, Wenkert D, Mumm S, Whyte MP.

Am J Med Genet A. 2016 Apr;170A(4):978-85. doi: 10.1002/ajmg.a.37536. Epub 2016 Jan 14. Review.


Congenital insensitivity to pain: Fracturing without apparent skeletal pathobiology caused by an autosomal dominant, second mutation in SCN11A encoding voltage-gated sodium channel 1.9.

Phatarakijnirund V, Mumm S, McAlister WH, Novack DV, Wenkert D, Clements KL, Whyte MP.

Bone. 2016 Mar;84:289-298. doi: 10.1016/j.bone.2015.11.022. Epub 2015 Dec 31.


Herpes Zoster Reactivation in Patients With Rheumatoid Arthritis: Analysis of Disease Characteristics and Disease-Modifying Antirheumatic Drugs.

Pappas DA, Hooper MM, Kremer JM, Reed G, Shan Y, Wenkert D, Greenberg JD, Curtis JR.

Arthritis Care Res (Hoboken). 2015 Dec;67(12):1671-8. doi: 10.1002/acr.22628.


Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients.

Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, Coburn SP, Wagy S, Griffin DM, Ericson KL, Mumm S.

Bone. 2015 Jun;75:229-39. doi: 10.1016/j.bone.2015.02.022. Epub 2015 Feb 27.


PHEX 3'-UTR c.*231A>G near the polyadenylation signal is a relatively common, mild, American mutation that masquerades as sporadic or X-linked recessive hypophosphatemic rickets.

Mumm S, Huskey M, Cajic A, Wollberg V, Zhang F, Madson KL, Wenkert D, McAlister WH, Gottesman GS, Whyte MP.

J Bone Miner Res. 2015 Jan;30(1):137-43. doi: 10.1002/jbmr.2307.


Multicentric carpotarsal osteolysis syndrome is caused by only a few domain-specific mutations in MAFB, a negative regulator of RANKL-induced osteoclastogenesis.

Mumm S, Huskey M, Duan S, Wenkert D, Madson KL, Gottesman GS, Nenninger AR, Laxer RM, McAlister WH, Whyte MP.

Am J Med Genet A. 2014 Sep;164A(9):2287-93. doi: 10.1002/ajmg.a.36641. Epub 2014 Jul 2.


Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports.

Hooper M, Wenkert D, Bitman B, Dias VC, Bartley Y.

Pediatr Rheumatol Online J. 2013 Oct 2;11(1):35. doi: 10.1186/1546-0096-11-35.


Rheumatoid arthritis disease activity and disability affect the risk of serious infection events in RADIUS 1.

Weaver A, Troum O, Hooper M, Koenig AS, Chaudhari S, Feng J, Wenkert D.

J Rheumatol. 2013 Aug;40(8):1275-81. doi: 10.3899/jrheum.121288. Epub 2013 Jun 15.


A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.

Lebwohl MG, Kircik L, Callis Duffin K, Pariser D, Hooper M, Wenkert D, Thompson EH, Yang J, Kricorian G, Koo J.

J Am Acad Dermatol. 2013 Sep;69(3):385-92. doi: 10.1016/j.jaad.2013.03.031. Epub 2013 May 1.


Dual-energy X-ray absorptiometry interpretation: a simple equation for height correction in preteenage children.

Zhang F, Whyte MP, Wenkert D.

J Clin Densitom. 2012 Jul-Sep;15(3):267-74. doi: 10.1016/j.jocd.2012.01.004. Epub 2012 Mar 16.


Enzyme-replacement therapy in life-threatening hypophosphatasia.

Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, Van Sickle BJ, Simmons JH, Edgar TS, Bauer ML, Hamdan MA, Bishop N, Lutz RE, McGinn M, Craig S, Moore JN, Taylor JW, Cleveland RH, Cranley WR, Lim R, Thacher TD, Mayhew JE, Downs M, Millán JL, Skrinar AM, Crine P, Landy H.

N Engl J Med. 2012 Mar 8;366(10):904-13. doi: 10.1056/NEJMoa1106173.


Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1.

Whyte MP, Wenkert D, Demertzis JL, DiCarlo EF, Westenberg E, Mumm S.

J Bone Miner Res. 2012 Mar;27(3):729-37. doi: 10.1002/jbmr.1473.


Hypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review).

Wenkert D, McAlister WH, Coburn SP, Zerega JA, Ryan LM, Ericson KL, Hersh JH, Mumm S, Whyte MP.

J Bone Miner Res. 2011 Oct;26(10):2389-98. doi: 10.1002/jbmr.454. Review.


Benzoquinone ansamycin 17AAG binds to mitochondrial voltage-dependent anion channel and inhibits cell invasion.

Xie Q, Wondergem R, Shen Y, Cavey G, Ke J, Thompson R, Bradley R, Daugherty-Holtrop J, Xu Y, Chen E, Omar H, Rosen N, Wenkert D, Xu HE, Vande Woude GF.

Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4105-10. doi: 10.1073/pnas.1015181108. Epub 2011 Feb 22. Erratum in: Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5472. Daughtery-Holtrop, Jennifer [corrected to Daugherty-Holtrop, Jennifer].


In Vitro Activity of Geldanamycin Derivatives against Schistosoma japonicum and Brugia malayi.

Wenkert D, Ramirez B, Shen Y, Kron MA.

J Parasitol Res. 2010;2010:716498. doi: 10.1155/2010/716498. Epub 2010 Dec 29.


Dysosteosclerosis presents as an "osteoclast-poor" form of osteopetrosis: comprehensive investigation of a 3-year-old girl and literature review.

Whyte MP, Wenkert D, McAlister WH, Novack DV, Nenninger AR, Zhang X, Huskey M, Mumm S.

J Bone Miner Res. 2010 Nov;25(11):2527-39. doi: 10.1002/jbmr.131. Review.


Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia.

Whyte MP, Wenkert D, McAlister WH, Mughal MZ, Freemont AJ, Whitehouse R, Baildam EM, Coburn SP, Ryan LM, Mumm S.

J Bone Miner Res. 2009 Aug;24(8):1493-505. doi: 10.1359/jbmr.090308.


Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases.

Whyte MP, McAlister WH, Novack DV, Clements KL, Schoenecker PL, Wenkert D.

J Bone Miner Res. 2008 Oct;23(10):1698-707. doi: 10.1359/jbmr.080511.


Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions.

Rauch F, Plotkin H, DiMeglio L, Engelbert RH, Henderson RC, Munns C, Wenkert D, Zeitler P.

J Clin Densitom. 2008 Jan-Mar;11(1):22-8. doi: 10.1016/j.jocd.2007.12.003.


Absence of MMP2 mutation in idiopathic multicentric osteolysis with nephropathy.

Wenkert D, Mumm S, Wiegand SM, McAlister WH, Whyte MP.

Clin Orthop Relat Res. 2007 Sep;462:80-6.


Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts.

Cahill RA, Wenkert D, Perlman SA, Steele A, Coburn SP, McAlister WH, Mumm S, Whyte MP.

J Clin Endocrinol Metab. 2007 Aug;92(8):2923-30. Epub 2007 May 22.


Deactivating germline mutations in LEMD3 cause osteopoikilosis and Buschke-Ollendorff syndrome, but not sporadic melorheostosis.

Mumm S, Wenkert D, Zhang X, McAlister WH, Mier RJ, Whyte MP.

J Bone Miner Res. 2007 Feb;22(2):243-50.


Skeletal changes in epidermal nevus syndrome: does focal bone disease harbor clues concerning pathogenesis?

Heike CL, Cunningham ML, Steiner RD, Wenkert D, Hornung RL, Gruss JS, Gannon FH, McAlister WH, Mumm S, Whyte MP.

Am J Med Genet A. 2005 Dec 1;139A(2):67-77.


Geldanamycin derivative inhibition of HGF/SF-mediated Met tyrosine kinase receptor-dependent urokinase-plasminogen activation.

Shen Y, Xie Q, Norberg M, Sausville E, Vande Woude G, Wenkert D.

Bioorg Med Chem. 2005 Aug 15;13(16):4960-71.


Geldanamycins exquisitely inhibit HGF/SF-mediated tumor cell invasion.

Xie Q, Gao CF, Shinomiya N, Sausville E, Hay R, Gustafson M, Shen Y, Wenkert D, Vande Woude GF.

Oncogene. 2005 May 26;24(23):3697-707.


Bisphosphonate-induced osteopetrosis.

Whyte MP, Wenkert D, Clements KL, McAlister WH, Mumm S.

N Engl J Med. 2003 Jul 31;349(5):457-63. No abstract available.


Congenital blindness and osteoporosis-pseudoglioma syndrome.

Lee DH, Wenkert D, Whyte MP, Trese MT, Cruz OA.

J AAPOS. 2003 Feb;7(1):75-7.


N-methylated 5-alkenyloxazolium salt transformations.

Wenkert D, Chen TF, Ramachandran K, Valasinas L, Weng Ll, McPhail AT.

Org Lett. 2001 Jul 26;3(15):2301-3.


Functional characterization of five V2 vasopressin receptor gene mutations.

Wenkert D, Schoneberg T, Merendino JJ Jr, Rodriguez Pena MS, Vinitsky R, Goldsmith PK, Wess J, Spiegel AM.

Mol Cell Endocrinol. 1996 Nov 29;124(1-2):43-50.


Novel mutations in the V2 vasopressin receptor gene of patients with X-linked nephrogenic diabetes insipidus.

Wenkert D, Merendino JJ Jr, Shenker A, Thambi N, Robertson GL, Moses AM, Spiegel AM.

Hum Mol Genet. 1994 Aug;3(8):1429-30. No abstract available.


Supplemental Content

Loading ...
Support Center